In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, Mangalam Drugs & Organics has informed that it enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.